Biomo-Corax-Gruppe

The Biomo-Corax-Gruppe is a German family-owned pharmaceutical group made up of biomo pharma GmbH and corax pharma, and it is run by the second generation of the founding family. Its best-known operating company, biomo pharma GmbH, is a medium-sized pharmaceutical manufacturer headquartered in Hennef in the Rhineland. The business was founded in 1986 by Dr. Karl-Georg Mothes, originally in Siegburg, and has grown from what the company itself describes as a garage firm into an independent, family-led pharmaceutical company. biomo pharma develops, manufactures and distributes prescription medicines, OTC drugs and food supplements. Its portfolio has historically included generics in therapeutic areas such as neurology, diabetology, gastroenterology, urology and orthopaedics, as well as phytotherapeutics and minerals. Over time the company has shifted its commercial focus toward niche and self-payer markets, while remaining an active partner of statutory health insurers in Germany through discount contracts with their preparations. The group's history includes a series of product firsts and strategic moves: the launch of its first antidiabetic in 1998, its first antidepressant in 2000, its first scabies preparation in 2012, its first potency medicine in 2018 and its first contraceptive in 2019. In 2007 biomo won important active ingredients, including omeprazole, in the first major AOK discount contract tender. The second generation entered the management in 2009, and in 2020 the aknederm brand was successfully repositioned through influencer marketing. According to German Wikipedia, the Biomo-Corax-Gruppe generated revenue of around 120 million euros in 2007 with roughly 400 employees. The group presents itself as putting people at the centre of its work, and in 2026 biomo pharma celebrates its 40th anniversary. The group remains privately held and independent, with its headquarters in Hennef and products sold worldwide.

The Biomo-Corax-Gruppe traces its origins to 1986, when Dr. Karl-Georg Mothes founded biomo Arzneimittel Vertriebs GmbH in Siegburg, Germany. In 1987 the company was renamed biomo Naturmedizin GmbH, and the gepepharm GmbH was founded. This early phase established the group's roots in natural medicine and pharmaceutical distribution. In 1998 biomo launched its first antidiabetic product, marking an expansion into prescription generics. In 2000 the company was renamed biomo pharma GmbH and introduced its first antidepressant. The following years brought further growth and family involvement: in 2003 pharmacist Diane Mothes-Grossmann joined the biomo group, and in 2004 Patrick Mothes joined as well, alongside an expansion of the manufacturing authorization. A major commercial milestone came in 2007, when biomo won important active ingredients, including omeprazole, in the first major AOK discount contract tender. In 2009 the second generation entered the management, signalling a generational transition. The group continued to add new therapeutic areas: in 2012 it introduced its first scabies preparation, and in 2013 it focused its products on niche and self-payer markets. In 2018 biomo launched its first potency medicine, followed in 2019 by its first contraceptive. In 2020 the company successfully repositioned its aknederm brand through influencer marketing, reflecting a modern approach to consumer-facing dermatology. According to German Wikipedia, the Biomo-Corax-Gruppe generated revenue of around 120 million euros in 2007 with roughly 400 employees. The group describes itself as having grown from a garage firm into a medium-sized, family-run pharmaceutical company headquartered in Hennef, with products sold worldwide. In 2026 biomo pharma celebrates its 40th anniversary, a milestone the company is using to reflect on its history and future.

• 2026

  biomo pharma celebrates its 40th anniversary.

• 2020

  Successful repositioning of the aknederm brand through influencer marketing.

• 2019

  Introduction of biomo's first contraceptive.

• 2018

  Introduction of biomo's first potency medicine.

• 2013

  Focus of products on niche and self-payer markets.

• 2012

  Introduction of biomo's first scabies preparation.

• 2009

  Second generation enters the management.

• 2007

  biomo wins important active ingredients (including omeprazole) in the first major AOK discount contract tender.

• 2004

  Expansion of manufacturing authorization; Patrick Mothes joins the biomo group.

• 2003

  Pharmacist Diane Mothes-Grossmann joins the biomo group.

• 2000

  Renamed biomo pharma GmbH; market launch of the first antidepressant.

• 1998

  Market launch of the first antidiabetic.

• 1987

  Renamed biomo Naturmedizin GmbH; gepepharm GmbH founded.

• 1986

  biomo Arzneimittel Vertriebs GmbH founded by Dr. Karl-Georg Mothes in Siegburg.

Independent, family-run medium-sized pharmaceutical group focused on quality, trust and niche/self-payer markets, with a mission to create sustainable value for patients.

• Prescription medicines

  Generics in areas such as neurology, diabetology, gastroenterology, urology and orthopaedics.

• OTC drugs

  Over-the-counter medicines.

• Food supplements

  Nutritional supplements.

• Phytotherapeutics

  Plant-based therapeutic products.

• Minerals

  Mineral-based products.

• aknederm

  Dermatological brand repositioned in 2020.

• aknederm influencer marketing

1. 1biomo pharma GmbH – Pharmaunternehmen aus Hennefbiomopharma.de
2. 2Unternehmen - biomopharmabiomopharma.de
3. 3Biomo-Corax-Gruppe - Wikidatawikidata.org
4. 4Biomo-Corax-Gruppe - Wikipediade.wikipedia.org